Navigating the complexities of antithrombotic therapy after LAAO
EuroIntervention
.
2024 Mar 4;20(5):e276-e277.
doi: 10.4244/EIJ-E-24-00001.
Author
Mohamad Alkhouli
1
Affiliation
1
Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN, USA.
PMID:
38436371
PMCID:
PMC10905190
(available on
2025-03-04
)
DOI:
10.4244/EIJ-E-24-00001
No abstract available
MeSH terms
Fibrinolytic Agents* / adverse effects
Humans
Substances
Fibrinolytic Agents